Concourse Financial Group Securities, Inc. Harvard Bioscience Inc Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding HBIO
# of Institutions
73Shares Held
22.1MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD4.05MShares$2.31 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.62 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$1.22 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$1.06 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$855,8590.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $23.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...